Instructions for Tilorone tablets
Description Tilorone
The tablets are round, biconvex and covered with an orange film sheath. On the cross-section you can see an orange core with small white spots.
Active Components
The main active ingredient of the drug is tilorone dihydrochloride.
Release Form
Pills.
Composition Tilorone
Each tablet contains:
tilorone dihydrochloride
Pharmacological effect
Said preparation exhibits the properties of antiviral and immunostimulating agents for producing interferons. Thylorone activates the synthesis of various types of interferons (alpha, beta, gamma, and lambda) in humans. The primary cells that produce interferon are the epithelial cells of the intestine, hepatocytes, T cells, neutrophils, and granulocytes.
After oral dosing, most interferon is synthesized in the following order: intestine, liver, blood, within 4 to 24 hours. Thylorone has both immunomodulatory and antiviral effects, activating interferon synthesis in white blood cells and promoting bone marrow stem cell activity, leading to increased antibody production. It also helps decrease immunodepression and normalize the ratio between T suppressor cells and T helper cells.
Indications for use Tilorone
Complex therapy: Children 7 to 18 years: Treatment of influenza and other acute respiratory viral infections (SARS)
Adults: Treatment of influenza and other SARS, treatment of herpes infection.
Adults:
It is taken to prevent influenza and other flu-like infections.
ICD-10 Code
A60 Anogenital herpetic virus infection [herpes simplex]
B00 Herpes virus infections [herpes simplex]
J06.9 Acute upper respiratory infection, unspecified
J10 Influenza due to identified seasonal influenza virus
Z29.8 Other specified preventive measures
Method of application and dosage
Tylorone is taken by mouth after eating. For influenza and other acute respiratory viral infections (ARVIs), 125 mg a day should be used for the first two days, followed by 125 mg at 48 hours. The total dose per course will be 750 mg. For influenza and SARS prophylaxis, 125 mg once a week for 6 weeks is recommended, which is also 750 mg for the whole course. Treatment of herpetic infections is 125 mg given for the first two days, then 125 mg again at 48 hours. The treatment course is 125 mg - 250 mg. If flu or SARS symptoms persist for more than four days, people should see a doctor.
Comprehensive therapy: Children aged seven to eighteen years:
Treatment of influenza, colds, and other acute respiratory viral infections (SARS)
Adults: Treatment of influenza, colds and other SARS, treatment of herpes infection.
Adults:
It is taken to prevent influenza and other flu-like infections.
